745-62-0 (前列腺素F1α,PGF1alpha (Prostaglandin F1alpha))

CAS号:
745-62-0
中文名称:
前列腺素F1α
英文名称:
PGF1alpha (Prostaglandin F1alpha)
分子式:
C20H36O5
分子量:
356.49684715271

前列腺素F1α(745-62-0)名称与标识符

名称

中文别名:
前列腺素F1alpha;前列腺素F1α;
英文别名:
Prost-13-en-1-oic acid,9,11,15-trihydroxy-, (9a,11a,13E,15S)-;PGF1α (Prostaglandin F1α);PROSTAGLANDIN F1ALPHA;Prostaglandin F1α;PGF1;PGF1ALPHA;PROSTAGLANDIN F1A;prostaglandinf1;PROSTAGLANDINS F1ALPHA;protaglandinf1;syntheticwhitecrystallinesolid;SR-01000946441-1;7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid;C06475;PGF1 alpha (Prostaglandin F1 alpha );NCGC00021875-03;9a,11a,15(S)-trihydroxy-13-trans-prostenoic acid;CHEMBL1325783;U 18714;PGF1alpha (Prostaglandin F1alpha);(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-oic acid;HMS2231H22;PROST-13-EN-1-OIC ACID, 9,11,15-TRIHYDROXY-, (9-.ALPHA.,11-.ALPHA.,13E,15S);Prostaglandin F1alpha, synthetic;HMS1361K14;Prostaglandin F1??;HMS3402K14;Prost-13-en-1-oic acid, 9,11,15-trihydroxy-, (9-alpha,11-alpha,13E,15S);HMS3648J19;DTXSID901339475;Opera_ID_1669;3,5-dihydroxy-2-(3-hydroxy-1-octenyl)- (8CI)-cyclopentaneheptanoic acid;Prost-13-en-1-oic acid,9,11,15-trihydroxy-,(9a,11a,13e,15s)-;PGF1alpha, Prostaglandin F1alpha, powder;745-62-0;Prostaglandin F1;GTPL5412;NS00015161;(+)-(9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprost-13-en-1-oic acid;7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)cyclopentyl)heptanoic acid;7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid;(13E,15S)-9alpha,11alpha,15-trihydroxyprost-13-en-1-oic acid;9S,11R,15S-trihydroxy-13E-prostaenoic acid;LMFA03010137;3,5-dihydroxy-2-(3-hydroxy-1-octenyl)- (8CI)-cyclopentaneheptanoate;AKOS040756112;IDI1_033962;SCHEMBL1477281;SR-01000946441;Prostaglandin F1 alpha;MFCD00077862;MLS000069612;UNII-WJ72O6860W;BSPBio_001492;Cyclopentaneheptanoic acid, 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)-;Prostaglandin F1.alpha.;SMR000058791;HMS1791K14;CHEBI:28852;Protaglandin F1;9a,11a,15(S)-trihydroxy-13-trans-prostenoate;BML1-F09;WJ72O6860W;NCGC00021875-05;Q27088352;PGF 1-alpha;Prostaglandin f1-alpha;NCGC00021875-04;(9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid;HMS1989K14;PROSTAGLANDINF1ALPHA;G91316;Prostaglandin F1alpha Solution in Methanol, 100ug/mL;HY-113459;1ST164222-100M;CS-0059623;AE-641/01143032;

标识符

InChIKey:
DZUXGQBLFALXCR-CDIPTNKSSA-N
Inchi:
1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1
SMILES:
O[C@H]1C[C@H]([C@H](/C=C/[C@H](CCCCC)O)[C@H]1CCCCCCC(=O)O)O

前列腺素F1α(745-62-0)物化性质

实验特性

  • LogP : 3.26690
  • PSA : 97.99000
  • 折射率 : 1.6120 (estimate)
  • 沸点 : 409.31°C (rough estimate)
  • 熔点 : 102.5°C
  • 蒸气压 : 0.0±3.1 mmHg at 25°C
  • 闪点 : 286.3±26.6 °C
  • 颜色与性状 : 未确定
  • 溶解性 : 未确定
  • 密度 : 1.0321 (rough estimate)

计算特性

  • 精确分子量 : 356.25600
  • 氢键供体数量 : 4
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 13
  • 同位素质量 : 356.256
  • 重原子数量 : 25
  • 复杂度 : 396
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 5
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 1
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.5
  • 表面电荷 : 0
  • 拓扑分子极性表面积 : 98

前列腺素F1α(745-62-0)国际标准相关数据

EINECS:

前列腺素F1α(745-62-0)生产方法和用途

用途:
生化研究

前列腺素F1α(745-62-0)推荐厂家 更多厂家(8)

公司名称手机号/电话联系人QQ微信询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
上海甄准生物科技有限公司 13816009161
021-68920155
姜经理13816009161 3001086693
询单
上海赛可锐生物科技有限公司 13003271654
021-58000709
赛可锐生物 3004122151
询单
上海颖心实验室设备有限公司 17002132182
021-59178156
墨航琪 3146474380
询单
上海柯维化学技术有限公司 18901607656
021-64609169
白荷 3428632096 询单
上海阿拉丁生化科技股份有限公司 13167063860
13167063860
阿拉丁 3004013043
询单
上海鼓臣生物技术有限公司 19147740836
021-34675735
李心雨 1668592116
询单

前列腺素F1α(745-62-0)相关文献

前列腺素F1α(745-62-0)参考资料

Reaxys RN:
PubChem CID:

前列腺素F1α(745-62-0) MSDS

基础信息


Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
  Product identifiers
    Product name        : Prostaglandin F1α    
    CAS-No.        : 745-62-0    
  

Section 2. HAZARDS IDENTIFICATION
  Classification of the substance or mixture
    Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
    This substance is not classified as dangerous according to Directive 67/548/EEC.
  Label elements
    The product does not need to be labelled in accordance with EC directives or respective national laws.
  Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
  Substances
    : (9α,11α,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid
    Synonyms
    PGF1α
    Formula        : C20H36O5    
    Molecular Weight        : 356,50 g/mol    

Section 4. FIRST AID MEASURES
  Description of first aid measures
  If inhaled
    If breathed in, move person into fresh air. If not breathing, give artificial respiration.
  In case of skin contact
    Wash off with soap and plenty of water.
  In case of eye contact
    Flush eyes with water as a precaution.
  If swallowed
    Never give anything by mouth to an unconscious person. Rinse mouth with water.
  Most important symptoms and effects, both acute and delayed
    To the best of our knowledge, the chemical, physical, and toxicological properties have not been
    thoroughly investigated.
  Indication of any immediate medical attention and special treatment needed
    no data available

Section 5. FIREFIGHTING MEASURES
  Extinguishing media
  Suitable extinguishing media
    Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
  Special hazards arising from the substance or mixture
    Carbon oxides
  Advice for firefighters
    Wear self contained breathing apparatus for fire fighting if necessary.
  Further information
    no data available

Section 6. ACCIDENTAL RELEASE MEASURES
  Personal precautions, protective equipment and emergency procedures
    Avoid dust formation. Avoid breathing vapors, mist or gas.
  Environmental precautions
    Do not let product enter drains.
  Methods and materials for containment and cleaning up
    Sweep up and shovel. Keep in suitable, closed containers for disposal.
  Reference to other sections
    For disposal see section 13.

Section 7. HANDLING AND STORAGE
  Precautions for safe handling
    Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
    protection.
  Conditions for safe storage, including any incompatibilities
    Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
    Recommended storage temperature: -20 °C
  Specific end uses
    no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
  Control parameters
  Components with workplace control parameters
  Exposure controls
  Appropriate engineering controls
    General industrial hygiene practice.
  Personal protective equipment
  Eye/face protection
    Use equipment for eye protection tested and approved under appropriate government standards
    such as NIOSH (US) or EN 166(EU).
  Skin protection
    Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
    (without touching glove's outer surface) to avoid skin contact with this product. Dispose of
    contaminated gloves after use in accordance with applicable laws and good laboratory practices.
    Wash and dry hands.
    The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
    the standard EN 374 derived from it.
  Body Protection
    Choose body protection in relation to its type, to the concentration and amount of dangerous
    substances, and to the specific work-place., The type of protective equipment must be selected
    according to the concentration and amount of the dangerous substance at the specific workplace.
  Respiratory protection
    Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
    use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
    approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
  Information on basic physical and chemical properties
    a) Appearance        Form: solid    
    b) Odour        no data available    
    c) Odour Threshold        no data available    
    d) pH        no data available    
    e) Melting point/freezing        95 - 97 °C    
    point
    f) Initial boiling point and no data available
    boiling range
    g) Flash point        no data available    
    h) Evaporation rate        no data available    
    i) Flammability (solid, gas) no data available
    j) Upper/lower        no data available    
    flammability or
    explosive limits
    k) Vapour pressure        no data available    
    l) Vapour density        no data available    
    m) Relative density        no data available    
    n) Water solubility        0,002 g/l at 25 °C    
    o) Partition coefficient: n- no data available
    octanol/water
    p) Autoignition        no data available    
    temperature
    q) Decomposition        no data available    
    temperature
    r) Viscosity        no data available    
    s) Explosive properties        no data available    
    t) Oxidizing properties        no data available    
  Other safety information
    no data available

Section 10. STABILITY AND REACTIVITY
  Reactivity
    no data available
  Chemical stability
    no data available
  Possibility of hazardous reactions
    no data available
  Conditions to avoid
    no data available
  Incompatible materials
    Strong oxidizing agents
  Hazardous decomposition products
    Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
  Information on toxicological effects
  Acute toxicity
    no data available
  Skin corrosion/irritation
    no data available
  Serious eye damage/eye irritation
    no data available
  Respiratory or skin sensitization
    no data available
  Germ cell mutagenicity
    Genotoxicity in vivo - mouse - Intraperitoneal
    sperm
  Carcinogenicity
    IARC:        No component of this product present at levels greater than or equal to 0.1% is identified as    
    probable, possible or confirmed human carcinogen by IARC.
  Reproductive toxicity
    Reproductive toxicity - rat - Subcutaneous
    Effects on Fertility: Pre-implantation mortality (e.g., reduction in number of implants per female; total
    number of implants per corpora lutea). Effects on Fertility: Other measures of fertility
    Reproductive toxicity - mouse - Subcutaneous
    Paternal Effects: Spermatogenesis (including genetic material, sperm morphology,motility, and count).
    Paternal Effects: Prostate, seminal vessicle, Cowper's gland, accessory glands.
    Reproductive toxicity - mouse - Subcutaneous
    Effects on Fertility: Post-implantation mortality (e.g., dead and/or resorbed implants per total number of
    implants). Effects on Embryo or Fetus: Fetal death.
    Developmental Toxicity - rat - Subcutaneous
    Effects on Embryo or Fetus: Extra embryonic structures (e.g., placenta, umbilical cord). Effects on Embryo
    or Fetus: Fetotoxicity (except death, e.g., stunted fetus).
  Specific target organ toxicity - single exposure
    no data available
  Specific target organ toxicity - repeated exposure
    no data available
  Aspiration hazard
    no data available
  Potential health effects
  Inhalation        May be harmful if inhaled. May cause respiratory tract irritation.    
  Ingestion        May be harmful if swallowed.    
  Skin        May be harmful if absorbed through skin. May cause skin irritation.    
  Eyes
    May cause eye irritation.
  Signs and Symptoms of Exposure
    To the best of our knowledge, the chemical, physical, and toxicological properties have not been
    thoroughly investigated.
  Additional Information
    RTECS: GY4569700

Section 12. ECOLOGICAL INFORMATION
  Toxicity
    no data available
  Persistence and degradability
    no data available
  Bioaccumulative potential
    no data available
  Mobility in soil
    no data available
  Results of PBT and vPvB assessment
    no data available
  Other adverse effects
    no data available

Section 13. DISPOSAL CONSIDERATIONS
  Waste treatment methods
  Product
    Offer surplus and non-recyclable solutions to a licensed disposal company.
  Contaminated packaging
    Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
  UN number
    ADR/RID: -        IMDG: -        IATA: -    
  UN proper shipping name
    ADR/RID: Not dangerous goods
    IMDG: Not dangerous goods
    IATA:        Not dangerous goods    
  Transport hazard class(es)
    ADR/RID: -        IMDG: -        IATA: -    
  Packaging group
    ADR/RID: -        IMDG: -        IATA: -    
  Environmental hazards
    ADR/RID: no        IMDG Marine pollutant: no        IATA: no    
  Special precautions for user
    no data available

Section 15. REGULATORY INFORMATION
    This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
  Safety, health and environmental regulations/legislation specific for the substance or mixture
    no data available
  Chemical Safety Assessment


SECTION 16 - ADDITIONAL INFORMATION
N/A